|
Status |
Public on Feb 23, 2022 |
Title |
Genome-wide expression profiling of melanoma cells (cancer cell lines and patient derived xenograft tumor models) treated with ARN22089 inhibitor |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation(s) |
35385746 |
|
Submission date |
Feb 22, 2022 |
Last update date |
May 25, 2022 |
Contact name |
Anand Ganesan |
E-mail(s) |
aganesan@hs.uci.edu
|
Phone |
(949) 824-2926
|
Organization name |
University of California, Irvine
|
Department |
Dermatology
|
Street address |
839 Health Science Ct.
|
City |
Irvine |
State/province |
CA |
ZIP/Postal code |
92697 |
Country |
USA |
|
|
Platforms (1) |
GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
Samples (24)
|
|
This SuperSeries is composed of the following SubSeries: |
GSE197068 |
Genome-wide expression profile of human melanoma patient derived xenograft (PDX) tumors that were treated with ARN22089 at 0 (vehicle), 10 mg/kg and 25 mg/kg IV in NSG mice (NOD.Cg-Prkdcscid IL2rgtm1Wjl/SzJ) |
GSE197069 |
Genome-wide expression profile of human melanoma cell line WM3248 treated with ARN22089 at 0, 4, 6 µM dosing for 24 h |
|
Relations |
BioProject |
PRJNA809370 |